Kilickap, S. Et Al. 2019. Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?. 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Barcelona, Spain), 637.

Kilickap, S., Basal, F. B., DEMİRKAZIK, A., Gursoy, P., Demirci, U., ERMAN, M., ... Yumuk, F.(2019). Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC? . 44th Congress of the European-Society-for-Medical-Oncology (ESMO) (pp.637). Barcelona, Spain

Kilickap, S. Et Al. "Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?," 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 2019

Kilickap, S. Et Al. "Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?." 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain, pp.637, 2019

Kilickap, S. Et Al. (2019) . "Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?." 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain, p.637.

@conferencepaper{conferencepaper, author={S. Kilickap Et Al. }, title={Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?}, congress name={44th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Barcelona}, country={Spain}, year={2019}, pages={637} }